Clinical Trial 49932

Winter Park, FL 32789


Summary:

A phase 2/3, interventional safety, pharmacokinetics, and efficacy, open-label, multi-center, single-arm study to investigate orally administered pf-07321332 (nirmatrelvir)/ritonavir in nonhospitalized symptomatic pediatric participants with covid-19 who are at risk of progression to severe disease.


Qualified Participants Must:

• Ages birth to less than or equal to 18 years old
• confirmed SARS-CoV2 infection
• has at least 1 underlying medical characteristic associated with an increased risk of developing COVID-19 including Overweight or Obese, Immunosuppressive disease, Chronic Lung Disease, known Hypertension, Cardiovascular Disease, Type 1 or Type 2 Diabetes Mellitus, Chronic Kidney Disease, Sickle Cell Disease, Neurodevelopmental disorder


Qualified Participants May Receive:

Compensation may be available for qualified study participants


Available At:

CLINICAL SITE PARTNERS, LLC
1788 W. FAIRBANKS AVENUE
Winter Park, FL 32789
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.